Docusate Sodium Liquid
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-05-27
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 01:01:37
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients (per 5 mL)
Docusate Sodium 50 mg
OTC - PURPOSE SECTION
Purpose
Stool Softener
INDICATIONS & USAGE SECTION
Uses
Relief of occasional constipation
WARNINGS SECTION
Warnings
Do not use when
- abdominal pain, nausea, or vomiting are present unless directed by a doctor
- for more than one week unless directed by a doctor
Ask a doctore before use if you
- are taking mineral oil
- have noticed a sudden change in bowel habits that last more than two weeks
Stop use and ask doctor if
- you have no bowel movements within 3 days
- you have rectal bleeding
- these could be signs of a serious condition
- a skin rash occurs
- you experience throat irritation
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a doctor before use
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of accidental overdose, seek medical assistance or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- follow dosing directions below or use as directed by a physician
- must be given in a 6 oz to 8 oz glass of milk or fruit juice to prevent throat irritation
- may be taken as a single daily dose or in dividend dose
- take maximum dose daily until first bowel movement, dosage should then be reduced according to individual response
- do not exceed recommended dose
- shake well before using
1 teasponnful = 5 mL
| Age | Dose |
| Adults and children over 12 years of age | 1 to 6 teaspoons (50 mg - 300 mg) |
| Children under 12 years of age | Ask a doctor |
INACTIVE INGREDIENT SECTION
Inactive ingredients: FD&C red #40, flavor, methylparaben, poloxamer, polyethylene glycol, propylene glycol, propylparaben, sodium benzoate, sodium citrate, sucralose
DISTRIBUTED BY
ATLANTIC BIOLOGICALS CORP
MIAMI, FL 33179
OTC - QUESTIONS SECTION
Questions or comments? 1-800-509-7592
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1248119 | docusate sodium 50 MG in 5 mL Oral Suspension | PSN | 4 |
| 1248119 | docusate sodium 10 MG/ML Oral Suspension | SCD | 4 |
| 1248119 | docusate sodium 100 MG per 10 ML Oral Suspension | SY | 4 |
| 1248119 | docusate sodium 150 MG per 15 ML Oral Suspension | SY | 4 |
| 1248119 | docusate sodium 50 MG per 5 ML Oral Suspension | SY | 4 |
| 1248119 | DOSS Sodium 10 MG/ML Oral Suspension | SY | 4 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-1304-1 | 2025-03-28 | C162847 | 48780-1 | 2cef2736-59c6-d83d-e063-dadaa90ab31f | Docusate Sodium Liquid |
| 17856-1304-2 | 2025-03-28 | C162847 | 48780-1 | 2cef2736-59c6-d83d-e063-dadaa90ab31f | Docusate Sodium Liquid |
| 17856-1304-1 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-59c6-d83d-e063-dadaa90ab31f | Docusate Sodium Liquid |
| 17856-1304-2 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-59c6-d83d-e063-dadaa90ab31f | Docusate Sodium Liquid |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1304-1 | Docusate Sodium Liquid | 25 mL in 1 CUP, UNIT-DOSE | LIQUID | 25 | 4 | |
| 17856-1304-1 | Docusate Sodium Liquid | 50 in 1 BOX, UNIT-DOSE | LIQUID | 50 | 4 | |
| 17856-1304-2 | Docusate Sodium Liquid | 10 mL in 1 CUP, UNIT-DOSE | LIQUID | 10 | 4 | |
| 17856-1304-2 | Docusate Sodium Liquid | 72 in 1 BOX, UNIT-DOSE | LIQUID | 72 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1304 | DOCUSATE SODIUM LIQUID (DOCUSATE SODIUM) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 4 | 4 package rows | 20250529_b23ad877-644d-4fde-bb2e-a6b8a22966da.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-1304-2 | ML - Milliliter | 17856-1304 | 65b6c009-811c-4db9-8461-38e9a67a798b | 1 | 2026-02-05 |
Products#
Every source-derived product name is available through these pages.
- Docusate Sodium Liquid
- Docusate Sodium
- FD&C RED NO. 40
- METHYLPARABEN
- POLOXAMER 124
- POLYETHYLENE GLYCOL, UNSPECIFIED
- PROPYLENE GLYCOL
- PROPYLPARABEN
- WATER
- SODIUM BENZOATE
- SODIUM CITRATE
- SUCRALOSE
- DOCUSATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 17856-1304 | 17856-1304-1, 17856-1304-2 |
| 0536-1304 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| POLOXAMER 124 | 1S66E28KXA | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| DOCUSATE SODIUM | F05Q2T2JA0 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Docusate Sodium Liquid | DOCUSATE SODIUM | RUGBY LABORATORIES | e21d19d8-6c2d-4474-a663-dfe7e91ac320 | 2025-12-30 | Warnings | 0536-1304 |
| 361f75a0-918b-4a5d-e063-6294a90ae813 | b23ad877-644d-4fde-bb2e-a6b8a22966da | 2025-05-27 | Warnings | 361f75a0-918b-4a5d-e063-6294a90ae813 b23ad877-644d-4fde-bb2e-a6b8a22966da |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

